Global Pulmonary Drug Delivery Systems Sales Market Report 2020

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.

Market Analysis and Insights: Global Pulmonary Drug Delivery Systems Market
The global Pulmonary Drug Delivery Systems market size is projected to reach US$ 3741.8 million by 2026, from US$ 2923.3 million in 2020, at a CAGR of 4.2% during 2021-2026.

Global Pulmonary Drug Delivery Systems Scope and Market Size
The global Pulmonary Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Pulmonary Drug Delivery Systems market is segmented into
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)

Segment by Application, the Pulmonary Drug Delivery Systems market is segmented into
COPD
Asthma
Others

The Pulmonary Drug Delivery Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Pulmonary Drug Delivery Systems market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Pulmonary Drug Delivery Systems Market Share Analysis
Pulmonary Drug Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pulmonary Drug Delivery Systems business, the date to enter into the Pulmonary Drug Delivery Systems market, Pulmonary Drug Delivery Systems product introduction, recent developments, etc.

The major vendors covered:
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing